The Role of Insulin and IGF-1 in Fueling Tumour Growth

# The Role of Insulin and IGF-1 in Fueling Tumour Growth: The Metabolic Highway to Carcinogenesis

Overview

For decades, the prevailing medical orthodoxy has treated cancer as a chaotic game of genetic "bad luck"—a series of random mutations that occur within the nucleus of a cell, leading to uncontrollable growth. While genetic damage is undoubtedly present in malignant tissue, this narrative conveniently ignores the metabolic environment that allows, and even encourages, these mutations to thrive. At INNERSTANDING, we look deeper. We examine the soil, not just the seed. The most profound and overlooked driver of the modern cancer epidemic is the systemic collapse of metabolic health, specifically the chronic elevation of insulin and Insulin-like Growth Factor 1 (IGF-1).

In the United Kingdom, we are currently witnessing a public health catastrophe. With over 3 million people diagnosed with Type 2 diabetes and millions more living in a state of undiagnosed hyperinsulinaemia (chronically high insulin), the biological stage is set for a surge in oncological cases. This is not a coincidence; it is a direct consequence of a biochemical environment that prioritises growth over repair, and fuel storage over cellular integrity.

Insulin is traditionally viewed merely as a "blood sugar regulator," but this is a dangerous oversimplification. Insulin is a master growth hormone. When levels remain pathologically high—driven by a diet of ultra-processed carbohydrates, frequent feeding, and sedentary lifestyles—it signals to every cell in the body that the environment is "growth-ready." Cancer cells, which possess an extraordinary density of insulin receptors, hijack this signal to fuel their own proliferation. Simultaneously, IGF-1, a potent mitogen (a substance that encourages cell division), acts as the "high-octane fuel" that drives the engine of tumour expansion. Together, they form a lethal axis that prevents apoptosis (programmed cell death) and accelerates the path to malignancy.

This article will expose the cellular mechanisms, the systemic failures, and the environmental triggers that have turned a vital survival mechanism—storing energy—into a biological death sentence for millions.

##

##

The Biology — How It Works

To understand how insulin and IGF-1 fuel cancer, we must first deconstruct their roles in human physiology. Insulin is a peptide hormone produced by the beta cells of the pancreas. Its primary role is to maintain glucose homeostasis. However, its secondary roles are equally critical: it facilitates the uptake of amino acids, promotes lipid storage (lipogenesis), and acts as a primary signalling molecule for the anabolic (building up) state of the body.

The Insulin Receptor (IR) and Malignancy

Every cell in the human body has insulin receptors, but cancer cells are unique. A hallmark of many aggressive tumours is the over-expression of insulin receptors (IR-A and IR-B isoforms). Specifically, the IR-A (fetal isoform) is frequently found in cancer cells; it has a high affinity not just for insulin, but also for IGF-1 and IGF-2. When insulin binds to these receptors, it doesn't just "lower blood sugar"; it activates a complex intracellular signalling cascade that tells the cell to "divide, survive, and consume."

The IGF-1 Pathway

Insulin-like Growth Factor 1 (IGF-1) is structurally similar to insulin but is primarily produced in the liver in response to Growth Hormone (GH) stimulation. IGF-1 is indispensable during childhood and adolescence for growth, but in an adult, chronically high levels are a major red flag.

In a healthy metabolic state, IGF-1 is kept in check by IGF Binding Proteins (IGFBPs). These proteins act like a sponge, soaking up excess IGF-1 so it cannot bind to cellular receptors. However, here is the metabolic "smoking gun": high levels of insulin suppress the production of IGFBPs. This means that hyperinsulinaemia creates a double-hit effect. Not only does insulin directly stimulate cancer growth, but it also increases the "bioavailability" of free IGF-1, allowing it to roam the bloodstream and bind to the IGF-1 Receptor (IGF-1R) on pre-cancerous or cancerous cells.

The Mitogenic Effect

The interaction between insulin/IGF-1 and their respective receptors is "mitogenic," meaning it triggers mitosis (cell division). In a healthy body, this is tightly regulated. In a body suffering from Metabolic Syndrome, this regulation vanishes. The body is essentially screaming "grow" at its tissues 24 hours a day. For a dormant cancer cell, this is the equivalent of pouring petrol onto a smouldering ember.

##

##

Mechanisms at the Cellular Level

The "how" of cancer growth is found in the intricate pathways of molecular biology. When insulin and IGF-1 dock onto a cell membrane, they trigger a series of events that fundamentally alter the cell's destiny.

The PI3K/Akt/mTOR Axis: The Master Switch

The most critical pathway activated by insulin and IGF-1 is the Phosphoinositide 3-kinase (PI3K) / Akt / mammalian Target of Rapamycin (mTOR) pathway.

• —PI3K: This enzyme is the first responder. Once insulin binds to the receptor, PI3K is activated, leading to the creation of signalling molecules.
• —Akt (Protein Kinase B): This is the "survival" protein. Akt inhibits the proteins that normally cause a damaged cell to commit suicide (apoptosis). It also stimulates the translocation of glucose transporters to the cell surface.
• —mTOR: This is the body’s master nutrient sensor. When mTOR is activated by insulin, it shuts down autophagy (the body's "recycling" and cleaning process) and turns on protein synthesis and cell growth.

In cancer cells, the PI3K/Akt/mTOR pathway is often permanently "stuck" in the ON position due to high circulating insulin. This creates a cell that refuses to die, consumes massive amounts of energy, and divides at an unnatural rate.

The Warburg Effect and Glucose Transport

Cancer cells have a peculiar way of breathing. Even in the presence of oxygen, they prefer to ferment glucose into lactate. This is known as the Warburg Effect. To sustain this inefficient but rapid energy production, cancer cells need massive amounts of glucose. Insulin facilitates this by upregulating GLUT1 (Glucose Transporter 1). While normal cells might wait for a signal to take in glucose, cancer cells stimulated by high insulin levels effectively "open the floodgates," ensuring they have a constant supply of sugar to fuel their fermentation process and rapid expansion.

Inhibition of Apoptosis

Under normal conditions, a cell with damaged DNA will be forced into apoptosis—the programmed death of the cell for the greater good of the organism. High levels of IGF-1 interfere with this process by activating anti-apoptotic proteins like Bcl-2 and Bcl-xL. This allows cells that should have been eliminated by the immune system or natural biological checkpoints to survive, replicate, and eventually form a tumour.

##

##

Environmental Threats and Biological Disruptors

The rise in hyperinsulinaemia and elevated IGF-1 is not a biological accident; it is the result of an environment that has become hostile to human metabolic health. Several key factors are driving this hormonal dysregulation in the UK.

The Refined Carbohydrate and Sugar Deluge

The most direct driver of hyperinsulinaemia is the consumption of ultra-processed foods (UPFs). The UK diet is now over 50% UPF. These foods—rich in refined flours, high-fructose corn syrup, and sucrose—cause massive spikes in blood glucose. The pancreas responds by pumping out huge quantities of insulin. Over time, cells become insulin resistant, requiring even more insulin to achieve the same effect. This leads to the chronic state of hyperinsulinaemia that fuels cancer.

Industrial Seed Oils and Oxidative Stress

Vegetable and seed oils (sunflower, rapeseed, corn, soybean) are ubiquitous in the British food supply. These oils are high in Linoleic Acid (LA), an omega-6 fatty acid that is highly prone to oxidation. When these oils are incorporated into cell membranes, they create a state of low-grade systemic inflammation and oxidative stress. This inflammation further impairs insulin signalling, driving the body toward higher insulin production and creating a pro-carcinogenic inflammatory milieu.

Endocrine Disruptors and "Obesogens"

We are also exposed to a cocktail of environmental chemicals that disrupt our hormonal balance.

• —Bisphenol A (BPA) and Phthalates: Found in plastics and food linings (often regulated by the Food Standards Agency (FSA), though many argue these regulations are too lax), these chemicals can mimic oestrogen and interfere with insulin sensitivity.
• —Atrazine and Glyphosate: Agricultural chemicals used in UK farming can disrupt the endocrine system, leading to metabolic dysfunction.
• —PFAS (Forever Chemicals): Widely present in the UK water supply, these chemicals have been linked to metabolic interference and increased cancer risk.

The Dairy Factor and IGF-1

Modern dairy production involves milking cows while they are pregnant, leading to milk that is naturally high in hormones, including bovine IGF-1. Furthermore, the consumption of dairy protein (specifically whey and casein) significantly stimulates the liver to produce more human IGF-1. For individuals already at risk of hormone-sensitive cancers (breast, prostate), the chronic stimulation of the IGF-1 pathway through high dairy intake is a factor that is frequently ignored by mainstream dietary advice.

##

##

The Cascade: From Exposure to Disease

The journey from a "normal" person to a cancer patient is often a decades-long cascade of metabolic failure. It rarely starts with a mutation; it starts with a metabolic shift.

• —Stage One: The Glucose Spike. The individual consumes a diet high in processed carbohydrates and sugars. Frequent "grazing" ensures that insulin levels never return to baseline.
• —Stage Two: Insulin Resistance. To protect themselves from the toxic effects of high glucose, cells "down-regulate" their insulin receptors. The pancreas compensates by producing even more insulin. This is the beginning of Hyperinsulinaemia.
• —Stage Three: Liver Overdrive. High insulin tells the liver to stop producing IGF Binding Proteins. The amount of "free" (active) IGF-1 in the blood rises sharply.
• —Stage Four: Cellular Transformation. Somewhere in the body, a cell undergoes a minor genetic mutation (which happens thousands of times daily in everyone). In a metabolically healthy person, this cell would be starved of growth signals or destroyed by the immune system. In this high-insulin/high-IGF-1 environment, the cell is fed and protected.
• —Stage Five: Angiogenesis and Growth. The high-insulin environment stimulates Vascular Endothelial Growth Factor (VEGF), encouraging the growth of new blood vessels to feed the budding tumour. The tumour begins its exponential growth phase, invisible to standard medical screening for years.
• —Stage Six: Clinical Diagnosis. By the time a tumour is large enough to be seen on a scan or felt as a lump, it has been "marinating" in a pro-growth hormonal soup for 5 to 10 years.

##

##

What the Mainstream Narrative Omits

The mainstream medical and pharmaceutical industry—including the Medicines and Healthcare products Regulatory Agency (MHRA) and the broader NHS infrastructure—focuses almost entirely on downstream interventions. We are told to "watch for symptoms" and rely on "early detection" through screenings. While screening has its place, it is a reactive strategy, not a preventative one.

The Lack of Insulin Testing

In the UK, when you go for a "General Health Check" on the NHS, they typically measure your Fasting Blood Glucose (FBG) or perhaps your HbA1c (average blood sugar). These are "late-stage" markers. Your body will fight tooth and nail to keep your blood sugar normal by pumping out extra insulin. Consequently, your blood sugar may look "perfect" for a decade while your insulin levels are sky-high. Mainstream medicine almost never tests Fasting Insulin. This is a catastrophic oversight. By failing to measure insulin, the NHS misses the opportunity to identify cancer-prone metabolic environments years before a diagnosis is made.

The Pharmaceutical Bias

The "war on cancer" is focused on finding the "magic bullet"—a drug that can kill the cancer cell without killing the patient. This approach is highly profitable for pharmaceutical companies. However, there is very little profit in telling the public to stop eating refined carbohydrates, to fast, or to lower their insulin. Furthermore, the mainstream narrative often ignores the role of hyperinsulinaemia in chemotherapy resistance. Research shows that high levels of insulin can actually protect cancer cells from the effects of chemotherapy and radiation, making treatments less effective and more toxic.

The Dietary Disconnect

If you visit a typical NHS oncology ward, you will often see patients being served high-sugar puddings, white bread, and sugary fruit juices. The justification is "getting calories in." This is scientifically illiterate. By feeding cancer patients sugar, the hospital is providing the very fuel (glucose) and the very growth signal (insulin) that the tumour needs to resist treatment and grow.

##

##

The UK Context

The United Kingdom is uniquely vulnerable to the insulin-cancer axis. Our socio-economic landscape and public health policies have created a perfect storm for metabolic disease.

The NHS Crisis and Metabolic Burden

The NHS is currently buckling under the weight of chronic disease. It is estimated that 10% of the entire NHS budget is spent on treating diabetes and its complications. This does not even account for the cost of cancers that were driven by the same metabolic dysfunction. The British healthcare system is designed to manage "sickness" rather than promote "wellness." The "Gold Standard" of care rarely includes metabolic restoration as a primary cancer therapy.

The "Food Desert" and High Street Culture

In many UK cities, "food deserts" exist where fresh, whole foods are expensive and difficult to find, while ultra-processed "deals" are ubiquitous. The "Meal Deal" culture—a sandwich (refined flour), a bag of crisps (seed oils), and a sugary drink—is a prescription for hyperinsulinaemia. This cultural norm, combined with the aggressive marketing of the "Big Food" industry, has made metabolic health almost impossible for the average citizen to maintain without significant effort and education.

Regulatory Failures

The Environment Agency and the FSA have been slow to act on endocrine-disrupting chemicals and the pervasive use of glyphosate in British agriculture. While the EU has stricter regulations on some of these substances, post-Brexit UK is at risk of "deregulation" that could lead to even higher exposures to environmental carcinogens that disrupt insulin sensitivity.

##

##

Protective Measures and Recovery Protocols

Understanding the role of insulin and IGF-1 is not meant to cause despair; it is meant to provide a roadmap for empowerment. We can actively "starve" the metabolic environment that cancer needs to thrive.

1. Achieve Insulin Sensitivity through Nutrition

The single most effective way to lower insulin and IGF-1 is to reduce the demand for them.

• —Strict Carbohydrate Restriction: Implementing a well-formulated Ketogenic Diet or a very low-carbohydrate approach. By keeping blood glucose low, the pancreas is not required to produce large amounts of insulin.
• —Elimination of Ultra-Processed Foods: Removing "industrial food-like substances" that contain hidden sugars and inflammatory seed oils.
• —Focus on High-Quality Protein and Fats: Prioritising grass-fed meats, wild-caught fish, and healthy fats like olive oil, avocado, and butter.

2. Therapeutic Fasting and Time-Restricted Feeding

Fasting is the most potent "metabolic reset" available.

• —Intermittent Fasting (16:8 or 18:6): By narrowing the window in which you eat, you allow insulin levels to drop to their "basal" or lowest levels for the majority of the day.
• —Extended Fasting (24–72 hours): Under medical supervision, longer fasts can trigger autophagy—the process where the body identifies and destroys damaged or pre-cancerous cells. This process is completely inhibited in the presence of high insulin.

3. Physical Intervention

• —Resistance Training: Muscle is the body's largest "glucose sink." By building muscle mass through weightlifting or bodyweight exercises, you increase your body’s ability to handle glucose, thereby reducing the need for high insulin levels.
• —Post-Prandial Movement: A simple 10-minute walk after meals can significantly blunt the glucose and insulin spike.

4. Supplementation and Metabolic Adjuvants

• —Berberine: A botanical compound that has been shown in numerous studies to be as effective as Metformin (a common diabetes drug) at improving insulin sensitivity and lowering blood glucose.
• —Magnesium: Essential for the proper function of the insulin receptor. Most people in the UK are chronically deficient in magnesium.
• —Vitamin D3/K2: Low Vitamin D levels are strongly correlated with both insulin resistance and increased cancer risk. In the UK, supplementation is essential, especially between October and April.

5. Environmental Detoxification

• —Water Filtration: Using high-quality filters to remove PFAS and other endocrine disruptors from tap water.
• —Avoidance of Plastics: Switching to glass or stainless steel for food storage and avoiding heating food in plastic containers.
• —Organic Produce: Choosing organic for the "Dirty Dozen" (the most pesticide-laden crops) to reduce exposure to insulin-disrupting chemicals like glyphosate.

##

##

Summary: Key Takeaways

The link between insulin, IGF-1, and cancer growth is a biological reality that can no longer be ignored. While the mainstream narrative continues to focus on genetic mutations and pharmaceutical interventions, the "truth-exposed" reality is that our metabolic health is the primary determinant of our oncological destiny.

• —Insulin is more than a sugar hormone; it is a potent growth factor that cancer cells use to fuel their survival and division.
• —Hyperinsulinaemia suppresses the body’s natural defences by lowering IGF-1 binding proteins and inhibiting autophagy and apoptosis.
• —The UK’s "modern" lifestyle—characterised by ultra-processed food, environmental toxins, and a lack of metabolic testing—is a perfect incubator for tumour growth.
• —The PI3K/Akt/mTOR pathway is the molecular bridge between poor metabolic health and the "unstoppable" growth of cancer cells.
• —Empowerment lies in metabolic restoration. By adopting low-carb nutrition, intermittent fasting, and reducing environmental exposures, we can create an internal environment where cancer simply cannot thrive.

The current trajectory of UK health is unsustainable. However, by understanding the biological mechanisms at play and taking decisive action to manage our insulin and IGF-1 levels, we can move from being passive victims of "bad luck" to being active architects of our own biological resilience. At INNERSTANDING, we believe that knowledge is the ultimate medicine. The "war on cancer" will not be won in a laboratory, but in the kitchens and lifestyles of those who choose to understand the truth.